AHA GUIDELINES Bundle (free trial)

2017 Update Incorporated - Valvular Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/362033

Contents of this Issue

Navigation

Page 46 of 63

47 Infectious Endocarditis Figure 7. Diagnosis and Treatment of IE Patient at Risk or With Suspected NVE or PVE Blood cultures × 2 TTE/TEE Modified Duke Criteria Definite or probable IE Antibiotic Rx (I) Temporarily discontinue VKA anticoagulation (IIa) Pacer/ICD present Large mobile vegetation (native valve) Recurrent emboli and persistent vegetations despite appropriate antibiotc Rx Infection of leads or device pocket NO YES Remove Hardware Early (I) Remove Hardware (IIa) Early Surgery (IIb) Surgery (I) Early Surgery a (I) a Early surgery is defined as during initial hospitalization before completion of a full therapeutic course of antibiotics. Early Surgery (IIa) Resistant organism (S. aureus, fungi) Valve surgery for IE Valve dysfunction causing HF Resistant organism (S. aureus, fungi) Heart block or abscess Persistent infection Relapsing PVE Evaluate for need and timing of surgery

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - 2017 Update Incorporated - Valvular Heart Disease